omega-n-methylarginine has been researched along with zopolrestat in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (zopolrestat) | Trials (zopolrestat) | Recent Studies (post-2010) (zopolrestat) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 86 | 2 | 24 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | zopolrestat (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.915 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.0153 | |
Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | 1.3545 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.0229 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.005 | |
Aldo-keto reductase family 1 member B7 | Rattus norvegicus (Norway rat) | 0.049 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG | 1 |
1 other study(ies) available for omega-n-methylarginine and zopolrestat
Article | Year |
---|---|
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea | 1993 |